Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
9.42 USD | +1.07% | -12.57% | -32.07% |
05-08 | Olema Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
04-02 | Goldman Sachs Initiates Olema Pharmaceuticals at Buy With $24 Price Target | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-32.07% | 521M | |
+25.27% | 44.96B | |
+0.31% | 42.65B | |
+46.00% | 41.85B | |
-5.31% | 29.04B | |
+10.55% | 26.08B | |
-20.96% | 19.03B | |
+6.93% | 12.75B | |
+28.76% | 12.06B | |
-3.73% | 11.75B |
- Stock Market
- Equities
- OLMA Stock
- News Olema Pharmaceuticals, Inc.
- Olema Pharmaceuticals Insider Sold Shares Worth $196,233, According to a Recent SEC Filing